Cancer in anaesthesia perspective

Ghazali, Abdul Majid and Mansor, Khairul Anam (2024) Cancer in anaesthesia perspective. Malaysian Society of Anaesthesiologists Year Book 2023/2024. pp. 5-9. ISSN 2462-1307

PDF - Published Version Restricted to Registered users only Download (245kB) | Request a copy

Abstract

Cancer represents a significant global health burden. In 2020, an estimated 19.3 million new cancer cases were reported worldwide, accompanied by nearly 10 million cancer-related deaths. Projections indicate that the incidence of cancer could rise to 28.4 million cases by 2040.1 Surgical resection is widely regarded as the primary treatment modality for solid malignant tumours. However, postsurgical cancer recurrence and metastasis remain the leading causes of cancer related mortality.2 Emerging evidence suggests that anaesthetic agents used during surgical ptrocedures may disrupt the delicate balance between tumour aggressiveness and the body’s immune surveillance, thereby contributing to cancer recurrence and metastasis. Consequently, it is imperative to identify the optimal anaesthetic agents for patients undergoing oncologic surgery

Item Type:	Article (Journal)
Uncontrolled Keywords:	Hypoxia upregulates the expression of hypoxia-inducible factor 1-alpha (HIF1A), vascular endothelial growth factor (VEGF) natural killer (NK)
Subjects:	R Medicine > RD Surgery > RD81 Anesthesiology
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine > Department of Anaesthesiology & Intensive Care
Depositing User:	dr abdul majid bin ghazali
Date Deposited:	09 Dec 2024 17:39
Last Modified:	09 Dec 2024 17:42
URI:	http://irep.iium.edu.my/id/eprint/116446

Actions (login required)

View Item